Compounded GLP-1
Compare quotes for compounded GLP-1, see whether a prescription is needed, what affects price, how fast quotes come back, and what happens after you submit.
About GLP-1
GLP-1 receptor agonists — semaglutide, tirzepatide, liraglutide — are injectable medications originally developed for type 2 diabetes and now widely used for weight management. Compounded versions are only available under specific FDA-permitted circumstances, such as a documented clinical reason the commercial product (Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda) is not suitable for the patient. Following the FDA's 2024 resolution of the tirzepatide and semaglutide shortages, compounded GLP-1s are no longer routinely available for supply or cost reasons. Compounding Finder routes patients to licensed U.S. 503A/503B pharmacies only when clinical eligibility is documented.
Current legal status of compounded GLP-1s (2026)
As of 2026, compounded semaglutide and tirzepatide are not legal to dispense under the shortage-based exceptions that were in effect in 2022–2024. The FDA declared both shortages resolved in late 2024, which removes the basis for 503A pharmacies to compound widely distributed copies of the commercial products.
Compounding is still permitted on a case-by-case basis under Section 503A — for example, when a specific patient has a documented allergy to an inactive ingredient in the commercial product, or needs a non-commercial strength for a documented clinical reason. Cost alone is not a valid basis for compounding. Liraglutide remains compoundable under the same case-by-case rules.
Which GLP-1s can be compounded and when
Compounding pharmacies currently prepare GLP-1 receptor agonists only for patients whose prescribers document a specific clinical reason the commercial product is not appropriate.
Documented reasons can include: allergies to polysorbate, benzyl alcohol, phenol, or other excipients in the branded product; the need for a non-commercial strength to support a titration or tapering protocol that the commercial product cannot match; or other medically documented circumstances. A pharmacy offering widely distributed compounded semaglutide or tirzepatide without that documentation is operating outside FDA guidance and should be a red flag.
Commercial GLP-1 products — and when they're the right answer
For most patients, the commercial branded products are the correct choice: Ozempic and Wegovy (semaglutide), Mounjaro and Zepbound (tirzepatide), Saxenda (liraglutide), and Rybelsus (oral semaglutide).
All are covered by most commercial insurance plans for appropriate indications, and both Novo Nordisk and Eli Lilly operate patient savings programs that can reduce out-of-pocket costs significantly. Eli Lilly's LillyDirect and Novo Nordisk's NovoCare also offer direct-pay options at lower monthly costs. If your prescriber does not have a documented clinical reason to compound, the commercial product plus manufacturer savings is the appropriate path.
What to expect from Compounding Finder on GLP-1 quotes
Compounding Finder accepts GLP-1 quote requests, but our pharmacy partners will only fill a prescription where the prescriber has documented clinical eligibility per Section 503A. We do not route quotes for patients seeking compounded GLP-1s solely for cost or convenience reasons.
If your provider has documented clinical eligibility, submit a quote request and we'll route it to licensed 503A and 503B compounding pharmacies. Otherwise, we recommend working with your provider on the commercial product plus available manufacturer savings programs.
Key Questions Before You Request Quotes
Can I get GLP-1 compounded?
Possibly. A licensed prescriber has to decide whether GLP-1 is appropriate, and a licensed compounding pharmacy has to confirm it can legally prepare the requested strength, form, and quantity.
Is a prescription needed?
Yes. Patient-specific 503A compounding is based on a valid prescription order or prescriber notation for an identified patient.
What affects price?
Strength, dosage form, quantity, ingredient sourcing, sterile versus non-sterile preparation, shipping requirements, and each pharmacy's workflow can all change the final quote.
How fast can I get quotes?
For routable requests, Compounding Finder typically returns quote options by email within 1-2 business days after you submit the request details.
What happens after I submit?
We review the request, route it to eligible licensed pharmacies, collect available options, and email you the quoted choices. You decide whether to move forward with a pharmacy.
Source notes: FDA explains that compounded drugs are not FDA-approved finished products and describes 503A compounding around patient-specific prescriptions. See Compounding and the FDA and Section 503A.
Related GLP-1 Quote Pages
How to Get GLP-1 Quotes
GLP-1 by State
Compare GLP-1 prices from licensed compounding pharmacies in your state:
Why Compare GLP-1 Prices?
Compounded medication prices vary significantly between pharmacies — sometimes by 300% or more for the exact same drug, strength, and formulation. Factors that affect pricing include the pharmacy’s location, their ingredient sourcing, and compounding volume.
By comparing quotes from multiple licensed pharmacies, you can find the best combination of price, quality, and convenience without spending hours making phone calls.
Frequently Asked Questions
Is compounded semaglutide still legal in 2026?
Compounded semaglutide is legal only on a case-by-case basis under Section 503A — for example, when a prescriber documents that the patient has an allergy to an inactive ingredient in Ozempic or Wegovy, or needs a non-commercial strength for a documented clinical reason. The shortage-based exception that allowed widely distributed compounding in 2022–2023 ended when the FDA declared the semaglutide shortage resolved in late 2024. Cost alone is not a valid basis for compounding.
Can I get compounded tirzepatide instead of Zepbound for cost savings?
No. Under FDA rules, cost is not a valid clinical reason to compound a drug that is commercially available. A prescriber must document a specific clinical reason — an allergy to an inactive ingredient, a need for a non-commercial strength, or another medically documented circumstance — for a compounded version to be appropriate. Eli Lilly's direct-pay program (LillyDirect) offers Zepbound at reduced out-of-pocket cost and is the appropriate path for most cost-sensitive patients.
What's the difference between compounded semaglutide and Ozempic or Wegovy?
Ozempic and Wegovy are FDA-approved branded semaglutide products manufactured by Novo Nordisk under strict quality controls. Compounded semaglutide is prepared by a licensed pharmacist under state pharmacy compounding standards and is not FDA-evaluated for batch safety or efficacy. The active ingredient can be the same, but compounded versions may differ in excipients, concentration, storage requirements, and potency tolerance. Compounded versions should only be used when commercial branded products are clinically inappropriate for a specific patient.
How do I know a GLP-1 pharmacy is legitimate?
Verify the pharmacy is licensed in your state through your state board of pharmacy, confirm they hold a compounding permit, and ask whether they are inspected by PCAB (Pharmacy Compounding Accreditation Board) or registered as a 503B outsourcing facility. Avoid any seller that ships GLP-1s without a prescription, non-U.S. online pharmacies, or any vendor marketing peptides as "research chemicals." Compounding Finder only works with licensed U.S. compounding pharmacies.
Get Free Quotes for Compounded GLP-1
Free quotes from licensed compounding pharmacies. No account, no obligation. Results in 1–2 business days.